Literature DB >> 8895672

Shortened survival of lung cancer patients initially presenting with pulmonary tuberculosis.

Y M Chen1, J Y Chao, C M Tsai, P Y Lee, R P Perng.   

Abstract

It has been reported that the incidence of lung cancer is higher in patients with pulmonary tuberculosis (TB). However, there is little information on the survival and clinical characteristics of these patients. We retrospectively reviewed the medical records of patients with coexisting pulmonary TB and lung cancer covering a period from 1988 to 1994. There were 31 such patients among a total of 3928 lung cancers diagnosed. Lung cancer patients had an increased risk of active pulmonary TB in comparison with the general population in Taiwan. Diabetes mellitus (DM) was found in 37.5% of patients who were diagnosed as having active pulmonary TB within 2 years before, or concurrent with, the diagnosis of lung cancer. However, none of the patients who had developed lung cancer before TB had a history of DM. Epidermoid carcinoma accounted for 64.5% of these cases. The patients who had developed active pulmonary TB before, or concurrently with, the diagnosis of lung cancer survived shorter than those who did not have pulmonary TB at diagnosis of lung cancer (P=0.007). Survival from diagnosis of pulmonary TB was longer in patients who developed the disease earlier than lung cancer (P=0.046). Survival from the time of diagnosis of lung cancer was significantly longer in patients who developed cancer earlier than active pulmonary TB (P=0.0048), those without DM (P=0.0132), those with an early tumor stage (P=0.002), and those given specific cancer treatment (P=0.0001). It is concluded that survival is shorter in lung cancer patients who present initially with active TB than in those who do not have TB.

Entities:  

Mesh:

Year:  1996        PMID: 8895672     DOI: 10.1093/oxfordjournals.jjco.a023240

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  7 in total

1.  A case of tuberculosis reactivation suspected of cancer progression during oral tyrosine kinase inhibitor treatment in a patient diagnosed as non-small cell lung cancer.

Authors:  Hwa Young Lee; Jin Woo Kim; Chang Dong Yeo
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

2.  Pleural tuberculosis following lung cancer chemotherapy: a report of two cases proven pathologically by pleural biopsy.

Authors:  Karan Madan; Navneet Singh; Ashim Das; Digambar Behera
Journal:  BMJ Case Rep       Date:  2013-01-22

3.  Concomitant active tuberculosis prolongs survival in non-small cell lung cancer: a study in a tuberculosis-endemic country.

Authors:  Chih-Hsi Kuo; Chun-Yu Lo; Fu-Tsai Chung; Kang-Yun Lee; Shu-Min Lin; Chun-Hua Wang; Chih-Chen Heh; Hao-Cheng Chen; Han-Pin Kuo
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

4.  Tuberculosis and diabetes mellitus - an underappreciated association.

Authors:  Marcin Skowroński; Dorota Zozulińska-Ziółkiewicz; Aleksander Barinow-Wojewódzki
Journal:  Arch Med Sci       Date:  2014-10-23       Impact factor: 3.318

5.  The effect of empirical and laboratory-confirmed tuberculosis on treatment outcomes.

Authors:  Osman Abdullahi; Ngari Moses; Deche Sanga; Willetts Annie
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

6.  The presence of old pulmonary tuberculosis is an independent prognostic factor for squamous cell lung cancer survival.

Authors:  Yiming Zhou; Zhenling Cui; Xiao Zhou; Chang Chen; Sen Jiang; Zhongyi Hu; Gening Jiang
Journal:  J Cardiothorac Surg       Date:  2013-05-06       Impact factor: 1.637

7.  Evaluation of coexistence of cancer and active tuberculosis; 16 case series.

Authors:  Beyhan Çakar; Aydın Çiledağ
Journal:  Respir Med Case Rep       Date:  2017-11-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.